|19.73||+0.3400||+1.75%||Vol 308.58K||1Y Perf 216.13%|
|Aug 14th, 2020 16:00 DELAYED|
|0.21 1.08%||- -%|
|Target Price||19.00||Analyst Rating||Strong Buy 1.40|
|Potential %||-3.70||Finscreener Ranking||★ 41.57|
|Insiders Trans % 3/6/12 mo.||-100/-100/60||Value Ranking||★ 42.79|
|Insiders Value % 3/6/12 mo.||-100/-100/61||Growth Ranking||+ 31.34|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/87||Income Ranking||— -|
|Market Cap||997.37M||Earnings Rating||Strong Buy|
|Price Range Ratio 52W %||92.75||Earnings Date||5th Aug 2020|
Today's Price Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Q04 2018||0.02||-0.74||-3 800.00|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.57|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||392.63K|
|Avg. Monthly Volume||615.32K|
|Avg. Quarterly Volume||644.91K|
Surgery Partners Inc. (NASDAQ: SGRY) stock closed at 19.73 per share at the end of the most recent trading day (a 1.75% change compared to the prior day closing price) with a volume of 308.58K shares and market capitalization of 997.37M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 11000 people. Surgery Partners Inc. CEO is Wayne S. Deveydt.
The one-year performance of Surgery Partners Inc. stock is 216.13%, while year-to-date (YTD) performance is 26.07%. SGRY stock has a five-year performance of %. Its 52-week range is between 4 and 20.96, which gives SGRY stock a 52-week price range ratio of 92.75%
Surgery Partners Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 1.62, a price-to-sale (PS) ratio of 0.57, a price to cashflow ratio of 3.30, a PEG ratio of 2.32, a ROA of -2.63%, a ROC of 0.11% and a ROE of -19.72%. The company’s profit margin is 1.17%, its EBITDA margin is 15.80%, and its revenue ttm is $1.78 Billion , which makes it $35.31 revenue per share.
Of the last four earnings reports from Surgery Partners Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.57 for the next earnings report. Surgery Partners Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Surgery Partners Inc. is Strong Buy (1.4), with a target price of $19, which is -3.70% compared to the current price. The earnings rating for Surgery Partners Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Surgery Partners Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Surgery Partners Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 38.69, ATR14 : 1.15, CCI20 : 75.26, Chaikin Money Flow : 0.20, MACD : 1.80, Money Flow Index : 69.53, ROC : 24.72, RSI : 69.23, STOCH (14,3) : 79.43, STOCH RSI : 0.14, UO : 57.70, Williams %R : -20.57), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Surgery Partners Inc. in the last 12-months were: J. Eric Evans (Buy at a value of $297 500), Teresa DeLuca (Buy at a value of $6 650), Teresa DeLuca (Sold 5 317 shares of value $109 530 ), Thomas F. Cowhey (Buy at a value of $150 000)
Copyright (c) 2020. All rights reserved. Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.com, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.